SenesTech (NASDAQ:SNES) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES) in a research note released on Monday morning. The firm issued a sell rating on the stock.

Separately, HC Wainwright increased their price objective on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.

SenesTech Stock Up 2.3 %

SNES opened at $2.24 on Monday. The company has a market cap of $2.32 million, a PE ratio of -0.22 and a beta of 0.09. The company has a quick ratio of 4.92, a current ratio of 6.32 and a debt-to-equity ratio of 0.05. SenesTech has a twelve month low of $1.90 and a twelve month high of $9.80. The company has a 50-day moving average price of $2.99 and a 200 day moving average price of $2.84.

SenesTech (NASDAQ:SNES) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, beating analysts’ consensus estimates of ($1.50) by $0.28. The company had revenue of $0.50 million during the quarter, compared to the consensus estimate of $0.71 million. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. Sell-side analysts expect that SenesTech will post -10.22 earnings per share for the current fiscal year.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.